Skip to main content
Smart Investors Daily
AF

NASDAQ · AFYA

Afya Limited

Consumer Defensive · Education & Training Services

$10.24

Down-$0.07 (-0.68%)

Updated Oct 29, 2026, 11:24 PM

SID Score

4.7/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.23B
P/E ratio
8.68
Dividend yield
2.27%
52-week range
$10.02 – $16.16
Volume
1.12M
Avg. volume
108.14K

Price performance · AFYA

AFYA price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 28, 2026

AFYA closed at $10.24 after 21 trading sessions, down 14.95% for the selected period.

Last close
$10.24
Period change
-14.95%
Period low
$10.24
Period high
$15.10
Daily close
View OHLC price history
AFYA OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 28, 2026$10.79$11.05$10.02$10.241.12M
Oct 27, 2026$10.95$11.085$10.55$10.83726.57K
Oct 26, 2026$11.71$12.54$10.05$10.641.77M
Oct 23, 2026$14.93$15.13$14.82$15.09119.09K
Oct 22, 2026$14.80$15.08$14.78$14.91185.26K
Oct 21, 2026$15.07$15.07$14.83$14.90107.96K
Oct 20, 2026$15.00$15.25$14.93$15.10335.02K
Oct 19, 2026$14.53$14.97$14.04$14.94373.09K
Oct 16, 2026$14.52$14.67$14.42$14.53194.16K
Oct 15, 2026$14.39$14.69$14.39$14.52163.39K
Oct 14, 2026$14.45$14.485$14.16$14.39156.67K
Oct 13, 2026$14.78$14.81$14.475$14.52306.63K
Oct 12, 2026$14.74$14.86$14.67$14.85117.8K
Oct 9, 2026$14.23$14.76$13.95$14.75269.16K
Oct 8, 2026$13.93$14.16$13.77$14.151.5M
Oct 7, 2026$14.13$14.28$13.80$13.90578.75K
Oct 6, 2026$13.41$13.94$13.41$13.915247.54K
Oct 5, 2026$13.36$13.4238$12.735$13.311.77M
Oct 2, 2026$12.21$12.315$11.94$12.22236.35K
Oct 1, 2026$12.13$12.24$11.82$12.08296.12K
Sep 30, 2026$11.87$12.33$11.855$12.04362.91K

Latest AFYA news

The latest Smart Investors Daily articles mentioning AFYA.

AFYA research

Overview

Company profile and research snapshot.

Company profile

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$18.25
Implied upside
—
Analysts
14
AFYA recent ratings
DateFirmRatingTarget
Oct 7, 2026JP MorganOverweight—
Jun 22, 2026JP MorganNeutral—
Apr 30, 2026JP MorganNeutral—
Feb 24, 2026B of A SecuritiesNeutral—
Feb 13, 2026Morgan StanleyUnderweight—
Open full forecast

News briefing

Generated Oct 29, 2026, 9:02 PM

Why Is AFYA Down Today?

Afya Limited (AFYA) declined 0.68% today as investors reassess overlooked factors in the healthcare education company's investment thesis. The modest pullback appears driven by renewed scrutiny on previously underappreciated headwinds affecting the business.

    Bottom line: Today's 0.68% decline appears driven by investor recalibration around previously overlooked factors affecting Afya's business thesis. Investors should review the specific concerns being raised and reassess whether they impact the company's long-term growth prospects or represent a potential buying opportunity for contrarian investors.

    Yahoo · Oct 27, 2026

    What Investors Overlooked Before Afya Slid

    If the Afya and Yduqs merger agreement grabbed your attention this year, you were not alone in wondering what it might mean for long term holders. Investors who held Afya from the start of the year are down 25.7%, including dividends. That result reflects every twist between January optimism and October merger headlines, not just one announcement. The real question is whether the clues available at the start made this outcome a surprise worth learning from. Afya has already moved. Pinpoint...

    Yahoo · Oct 25, 2026

    Is Afya (NASDAQ:AFYA) Still Undervalued Following Its Proposed Yduqs Merger?

    Afya merger announcement sets the stage Afya (AFYA) has drawn fresh attention after announcing a proposed merger with Yduqs that would form a healthcare education group targeting about BRL 10b in revenue and BRL 2.2b in projected synergies. Recent trading shows momentum building in Afya, with a 30-day share price return of 16.08% and a 90-day gain of 6.27% around the merger headlines, while the 1-year total shareholder return of 7.12% contrasts with slightly weaker 3-year and 5-year...

    AI research layers

    Interpretive context generated from the platform’s current data sources.

    No results

    AI research layers have not been published yet.